Interaction of stress and noradrenergic drugs in the control of picrotoxin-induced seizures

Epilepsy Research

Volumn 51, Issue 1-2, 2002, Pages 179-187

  Peričić, Danka ^a   Švob, Dubravka ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Alpha Methyl p tyrosine ( MPT); Convulsions; Desipramine; N (2 chloroethyl) N ethyl 2 bromobenzylamine (DSP 4); Picrotoxin; Stress

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; DESIPRAMINE; METIROSINE; PICROTOXIN;

ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONUS; CONTROLLED STUDY; DEATH; DRUG EFFECT; HINDLIMB; LATENT PERIOD; MALE; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; SEIZURE; STRESS; SWIMMING; SYMPTOM;

ADRENERGIC AGENTS; ADRENERGIC UPTAKE INHIBITORS; ALPHA-METHYLTYROSINE; ANALYSIS OF VARIANCE; ANIMALS; BENZYLAMINES; DESIPRAMINE; DRUG INTERACTIONS; ENZYME INHIBITORS; GABA ANTAGONISTS; MALE; MICE; MICE, INBRED CBA; PICROTOXIN; SEIZURES; STRESS; SWIMMING;

EID: 0036752206     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(02)00124-9     Document Type: Article

References (43)

1. Abel A.L., Berman R.F. Effects of water immersion stress on convulsions induced by pentylenetetrazole. Pharmacol. Biochem. Behav. 45:1993;823-825.
2. Bremner J.D., Krystal J.H., Southwick S.M., Charney D.S. Noradrenergic mechanisms in stress and anxiety 1, preclinical studies. Synapase. 23:1996;28-38.
3. Chauvel P., Trottier S. Role of noradrenergic ascending system in extinction of epileptic phenomena. Adv. Neurol. 44:1986;475-487.
4. 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology. 35:1996;63-70.
5. Clifford D.B., Rutherford J.L., Hicks F.G., Zorumski C.F. Acute effects of antidepressants on hippocampal seizures. Ann. Neurol. 18:1985;692-697.
6. Dailey J.W., Naritoku D.K. Antidepressants and seizures-clinical anecdotes overshadow neuroscience. Biochem. Pharmacol. 52:1996;1323-1329.
7. De Lima T.C., Rae G.A. Effects of cold-restraint and swim stress on convulsions induced by pentylentetrazol and electroshock: influence of naloxone pre-treatment. Pharmacol. Biochem. Behav. 40:1991;297-300.
8. Dooley D.J., Mogilnicka E., Delini-Stula A., Waechter F., Truog A., Wood J. Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin. Psychopharmacology. 81:1983;1-5.
9. Drugan R.C., McIntyre T.D., Alpern H.P., Maier S.F. Coping and seizure susceptibility: control over shock protects against bicuculline-induced seizures. Brain Res. 342:1985;9-17.
10. Drugan R.C., Basile A.S., Ha J-H, Ferland R.J. The protective effects of stress control may be mediated by increased brain levels of benzodiazepine receptor agonists. Brain Res. 661:1994;127-136.
11. Fritschy J.M., Grzanna R. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals. Neuroscience. 30:1989;181-197.
12. Frucht M.M., Quigg M., Schwaner C., Fountain N.B. Distribution of seizure precipitants among epilepsy syndromes. Epilepsia. 41:2000;1534-1539.
13. Gale K. Progression and generalization of seizure discharge: anatomical and neurochemical substrates. Epilepsia. 29:(Suppl. 2):1988;S15-S34.
14. 2-adrenoceptors in rat brain after short-term DSP-4 lesioning. Eur. J. Pharmacol. 249:1993;37-41.
15. Javors M.A., Houston J.P., Tekell J.L., Brannan S.K., Frazer A. Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine. Int. J. Neuropsychopharmacol. 3:2000;229-235.
16. Jonsson G., Hallman H., Ponzio F., Ross S. DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine) - a useful denervation tool for central and peripheral noradrenaline neurons. Eur. J. Pharmacol. 72:1981;173-188.
17. Kleinrok Z., Gustaw J., Czucwar S.J. Influence of antidepressant drugs on seizure susceptibility and the anticonvulsant activity of valproate in mice. J. Neural. Trans. Suppl. 34:1991;85-90.
18. Kosobud A.E., Crabbe J.C. Genetic correlations among inbred strain sensitivities to convulsions induced by 9 convulsant drugs. Brain Res. 526:1990;8-16.
19. Lai C.W., Trimble M.R. Stress and epilepsy. J. Epilepsy. 10:1997;177-186.
20. Mishra P.K., Burger R.L., Bettendorf A.F., Browning R.A., Jobe P.C. Role of norepinephrine in forebrain and brainstem seizures: Chemical lesioning of locus ceruleus with DSP4. Exp. Neurol. 125:1994;58-64.
21. Ojima K., Matsumoto K., Tohda M., Watanabe H. Hyperactivity of central noradrenergic and CRF systems is involved in social isolation-induced decrease in pentobarbital sleep. Brain Res. 684:1995;87-94.
22. Pacak K., Palkovits M., Yadid G., Kvetnansky R., Kopin I.J., Goldstein D.S. Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity. Am. J. Physiol. 275:1998;R1247-1255.
23. Palmer G.C., Harris E.W., Ray R., Stagnitto M.L., Schmiesing R.J. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol in mice and antagonism of MK801 binding in vitro. Arch. Int. Pharmacodyn. Ther. 317:1992;16-34.
24. Peričić D., Bujas M. Sex differences in bicuculline-induced convulsions: interaction with stress and ligands of benzodiazepine binding sites. Brain Res. 752:1997;279-284.
25. Peričić D., Bujas M., Mirković K., Jazvinšćak M. Effects of adrenalectomy and gonadectomy on sex and stress-induced differences in bicuculline-induced convulsions. Exp. Brain Res. 129:1999;451-456.
26. Peričić D., Švob D., Jazvinšćak M., Mirković K. Anticonvulsant effect of swim stress in mice. Pharmacol. Biochem. Behav. 66:2000a;879-886.
27. Peričić D., Jazvinšćak M., Švob D., Mirković K. β-1 adrenoceptor antagonists potentiate the anticonvulsant effect of swim stress in mice. Pharmacol. Biochem. Behav. 67:2000;507-510.
28. Peričić D., Jazvinšćak M., Švob D., Mirković K. Swim stress alters the behavioral response of mice to GABA-related and some GABA-unrelated convulsants. Epilepsy Res. 43:2001a;145-152.
29. 2-adrenoceptors in the anticonvulsant effect of swim stress in mice. Psychopharmacology. 158:2001b;87-93.
30. Philo R. Catecholamines and pinealectomy-induced convulsions in the gerbil (Meriones unguiculatus). Prog. Clin. Biol. Res. 92:1982;233-241.
31. Pisani F., Spina E., Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia. 40:(Suppl. 10):1999;S48-S56.
32. Pol O., Campmany L., Armario A. Inhibition of catecholamine synthesis with alpha-methyl-p-tyrosine apparently increases brain serotoninergic activity in the rat - no influence of previous chronic immobilization stress. Pharmacol. Biochem. Behav. 52:1995;107-112.
33. Rae G.A., Pereira G.H., De-Lima T.C. The influence of stress on convulsive parameters in the mouse. Neurosci. Biobehav. Rev. 14:1990;491-494.
34. Ross S.B., Renyi A.L. Tricyclic antidepressant agents, II, effect of oral administration on the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat. Acta Pharmacol. Toxicol. 36:1975;395-408.
35. Sato M. A study of psychomotor epilepsy with 'kindled' cat preparations. Folia Psychiat. Neurol. Jpn. 30:1976;425-434.
36. 3H]flunitrazepam cortical binding following stressful manipulations in rats. Brain Res. 189:1980;505-517.
37. Spector S., Cull C., Goldstein L.H. Seizure precipitants and perceived self-control of seizures in adults with poorly-controlled epilepsy. Epilepsy Res. 38:2000;207-216.
38. Stanford S.C. Central noradrenergic neurones and stress. Pharmacol. Ther. 68:1995;297-342.
39. Starr M.S. The role of dopamine in epilepsy. Synapse. 22:1996;159-194.
40. Statnick M.A., Maringsmith M.L., Clough R.W., Wang C., Dailey J.W., Jobe P.C., Browning R.A. Effect of 5,7-dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats. Life Sci. 59:1996;1763-1771.
41. Yan Q.S., Jobe P.C., Dailey J.W. Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis. Brain Res. 610:1993;24-31.
42. Yan Q.S., Jobe P.C., Dailey J.W. Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats. Br. J. Pharmacol. 115:1995;1314-1318.
43. Yoshimura Y., Dohi T., Tanaka S., Takada K., Tsujimoto A. Changes in convulsion susceptibility of lidocaine by alteration of brain catecholaminergic functions. Jpn. J. Pharmacol. 56:1991;85-91.